NOTE AB (publ) (STO:NOTE)
191.50
-0.20 (-0.10%)
Aug 1, 2025, 5:29 PM CET
Akoya Biosciences Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 257.03 | 248.03 | 319.96 | 254.24 | 194.06 | 115.66 | Upgrade |
Depreciation & Amortization | 117.52 | 117.52 | 108.17 | 79.95 | 63.34 | 46.53 | Upgrade |
Other Amortization | 4.07 | 4.07 | 3.67 | 3.29 | 3.04 | 2.77 | Upgrade |
Asset Writedown & Restructuring Costs | 12.31 | 12.31 | 16.12 | 20.22 | -3.15 | 26.85 | Upgrade |
Other Operating Activities | -20.1 | -0.1 | -43.9 | 1.3 | 29.73 | -5.59 | Upgrade |
Change in Accounts Receivable | 18.59 | 18.59 | 14.8 | -152.24 | -259.88 | 26.41 | Upgrade |
Change in Inventory | 268.12 | 268.12 | 16.64 | -317.8 | -422.21 | -15.57 | Upgrade |
Change in Other Net Operating Assets | -30.95 | -66.95 | -93.6 | 160.81 | 361.94 | -8.36 | Upgrade |
Operating Cash Flow | 626.59 | 601.59 | 341.84 | 49.79 | -33.13 | 188.7 | Upgrade |
Operating Cash Flow Growth | 28.44% | 75.98% | 586.58% | - | - | 95.57% | Upgrade |
Capital Expenditures | -100.26 | -89.26 | -91.73 | -46.41 | -27.49 | -15.94 | Upgrade |
Cash Acquisitions | -31.17 | -31.17 | -148.68 | -33.84 | -80.14 | - | Upgrade |
Sale (Purchase) of Intangibles | -17.14 | -17.14 | -3.24 | -0.71 | -1.15 | -1.03 | Upgrade |
Investing Cash Flow | -169.56 | -137.56 | -243.64 | -80.96 | -108.79 | -16.96 | Upgrade |
Long-Term Debt Issued | - | - | 60.67 | 63.42 | 220.21 | - | Upgrade |
Long-Term Debt Repaid | - | -174.41 | -72.51 | -60.59 | -58.1 | -183.51 | Upgrade |
Net Debt Issued (Repaid) | -174.41 | -174.41 | -11.84 | 2.84 | 162.11 | -183.51 | Upgrade |
Issuance of Common Stock | 5.08 | 5.08 | - | 11.66 | 6.12 | 11.65 | Upgrade |
Repurchase of Common Stock | -66.38 | -66.38 | - | - | - | - | Upgrade |
Other Financing Activities | -108 | - | - | - | - | - | Upgrade |
Financing Cash Flow | -343.71 | -235.71 | -11.84 | 14.5 | 168.23 | -171.86 | Upgrade |
Foreign Exchange Rate Adjustments | -9.97 | 13.03 | -4.18 | 5.15 | 5.12 | -4.76 | Upgrade |
Net Cash Flow | 103.34 | 241.34 | 82.18 | -11.52 | 31.44 | -4.88 | Upgrade |
Free Cash Flow | 526.32 | 512.32 | 250.11 | 3.38 | -60.62 | 172.77 | Upgrade |
Free Cash Flow Growth | 37.38% | 104.84% | 7306.37% | - | - | 121.16% | Upgrade |
Free Cash Flow Margin | 13.79% | 13.13% | 5.89% | 0.09% | -2.29% | 9.22% | Upgrade |
Free Cash Flow Per Share | 18.42 | 17.78 | 8.63 | 0.12 | -2.10 | 6.05 | Upgrade |
Cash Interest Paid | 8.12 | 8.12 | 10.47 | 15.01 | 6.38 | 4.9 | Upgrade |
Cash Income Tax Paid | 70.35 | 60.35 | 72.95 | 55.04 | 16.81 | 17.92 | Upgrade |
Levered Free Cash Flow | 442.52 | 394.74 | 124.23 | -105.13 | -197.75 | 155.55 | Upgrade |
Unlevered Free Cash Flow | 461.99 | 419.21 | 147.64 | -95.33 | -193.76 | 158.64 | Upgrade |
Change in Net Working Capital | -229 | -177.72 | 108.24 | 356.73 | 395.98 | -38.76 | Upgrade |
Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.